Video

ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL

Author(s):

Loretta J. Nastoupil, MD,Marc S. Hoffmann, MD

Loretta J. Nastoupil, MD, reviews data from the ZUMA-7 trial investigating the use of axicabtagene ciloleucel as a second-line therapy for large b-cell lymphoma.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity
View More
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity
View More
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity
View More
Related Content
Acute Lymphoblastic Leukemia | Image Credit: © Nittaya – stock.adobe.com
April 23rd 2025

Inati-Cel Induces High CR and MRD Negativity Rates in CD19+ R/R B-ALL

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

María-Victoria Mateos, MD, PhD, consultant physician, Hematology Department, associate professor, medicine, University of Salamanca
April 18th 2025

Cilta-Cel Emerges as a SOC in Lenalidomide-Refractory Multiple Myeloma

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

Dasatinib Plus CAR T-Cell Therapy in Ph+ ALL | Image credit: © Nittaya – stock.adobe.com
April 17th 2025

Dasatinib Plus CAR T-Cell Therapy Shows Efficacy in Ph+ Acute Lymphoblastic Leukemia

Kiavasch Mohammad Nejad Farid, MD, medical oncologist, Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
April 17th 2025

Responses With Compassionate Use of MDC-CAR-BCMA001 Support Further Study in R/R Myeloma and AL Amyloidosis